Literature DB >> 7752823

The universality of bioenergetic disease: the role of mitochondrial mutation and the putative inter-relationship between mitochondria and plasma membrane NADH oxidoreductase.

A Lawen1, R D Martinus, G L McMullen, P Nagley, F Vaillant, E J Wolvetang, A W Linnane.   

Abstract

Mesh:

Substances:

Year:  1994        PMID: 7752823     DOI: 10.1016/0098-2997(94)90009-4

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


× No keyword cloud information.
  5 in total

1.  Effects of nitric oxide donors on cybrids harbouring the mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) A3243G mitochondrial DNA mutation.

Authors:  Jagdeep K Sandhu; Caroline Sodja; Kevan McRae; Yan Li; Peter Rippstein; Yau-Huei Wei; Boleslaw Lach; Fay Lee; Septimiu Bucurescu; Mary-Ellen Harper; Marianna Sikorska
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

2.  Effectors of the mammalian plasma membrane NADH-oxidoreductase system. Short-chain ubiquinone analogues as potent stimulators.

Authors:  F Vaillant; J A Larm; G L McMullen; E J Wolvetang; A Lawen
Journal:  J Bioenerg Biomembr       Date:  1996-12       Impact factor: 2.945

Review 3.  Update on a tumor-associated NADH oxidase in gastric cancer cell growth.

Authors:  Hsiao-Ling Cheng; Yi-Hui Lee; Tein-Ming Yuan; Shi-Wen Chen; Pin-Ju Chueh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 4.  Is NADH effective in the treatment of Parkinson's disease?

Authors:  R H Swerdlow
Journal:  Drugs Aging       Date:  1998-10       Impact factor: 3.923

5.  A dietary source of coenzyme Q is essential for growth of long-lived Caenorhabditis elegans clk-1 mutants.

Authors:  T Jonassen; P L Larsen; C F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.